Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor
Indian Journal of Microbiology · 2025-03 · 65 (1) · 92-119
DOI: 10.1007/s12088-024-01330-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Microbiology, online erschienen am 21.06.2024. Verfasst von Amulya Jindal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh 250005 India. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The evolution of nanotechnology-driven lipid and metalloid-based nanoformulations has garnered significant attention for developing effective drug delivery systems with position/time precision and efficacy. This study focuses on challenges of blood-brain barrier (BBB) and their pivotal role in drug targeting in chronic diseases such as brain tumors (BTs). These formulations encapsulate therapeutic agents within lipidic matrices, enhancing drug solubility, bioavailability, and targeted delivery. The diverse lipid materials used in these nanoformulations highlight their biocompatibility and versatility, covering a wide range of drugs. Emphasis is placed on metal nanoparticles, liposomes, ethosomes, quantum dots, carbon nanotubes, nanorobots, and micelles. The analysis explores their drug loading, stability, release characteristics, and bioavailability modulation. It also delves into the enhanced-permeability and retention (EPR) effect, crucial for passive targeting of tumors. Recent nanocarrier systems enable better penetration of therapeutic compounds through the BBB, addressing treatment failures in invasive BTs.This review highlights the latest nanotechnology developments and potential therapeutic approaches, serving as a valuable resource for researchers, clinicians, and pharmaceutical scientists.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh 250005 India.
- SRM Modinagar College of Pharmacy, SRM Institute of Science and Technology (Deemed to Be University), Delhi-NCR Campus, Modinagar, Ghaziabad, Uttar Pradesh 201204 India.
- Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Sector 125, Noida, Uttar Pradesh 201301 India.
- Department of Electronics and Communication Engineering, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh 250005 India.
- Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh 221005 India.
ORCID-Profile: Ratneshwar Kumar Ratnesh
Zitieren
APA
Jindal, A., Mainuddin, Kumar, A., Ratnesh, R. K., & Singh, J. (2025). Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor. Indian Journal of Microbiology, 65(1), 92-119. https://doi.org/10.1007/s12088-024-01330-6
Vancouver
Jindal A, Mainuddin, Kumar A, Ratnesh RK, Singh J. Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor. Indian Journal of Microbiology. 2025;65(1):92-119. doi:10.1007/s12088-024-01330-6
BibTeX
@article{Jindal2025,
author = {Jindal, Amulya and Mainuddin and Kumar, Anoop and Ratnesh, Ratneshwar Kumar and Singh, Jay},
title = {Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor},
journal = {Indian Journal of Microbiology},
year = {2025},
volume = {65},
number = {1},
pages = {92--119},
doi = {10.1007/s12088-024-01330-6}
}
EUVIMED